NCT00367094

Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension

Efficacy and Safety of the Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With Benazepril

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 296 (planned)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate efficacy and safety data for benazepril/hydrochlorothiazide in adult Chinese patients with mild to moderate essential hypertension. Patients whose blood pressure is not adequately controlled with benazepril monotherapy during a 4 week run-in period will be randomly allocated to double blind treatment over 8 weeks with either a combination of benazepril/hydrochlorothiazide per day or continuation of benazepril per day.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	Benazepril plus hydrochlorothiazide

Timeline

• Start date: 2006-07-01
• First posted: 2006-08-22
• Last updated: 2007-07-09

Locations

1 site across 1 country: China